eAppendix 1: Data Source
As described in the main study, our data sources include the Medicare beneficiary enrollment database, Medicare fee-for-service claims (Part A and Part B) located on the Chronic Condition Warehouse (CCW) Virtual Research Data Center (VRDC) and Maryland Medicaid claims from the Maryland Department of Health and Mental Hygiene, provided to us through the Hilltop Institute. We also used files obtained from the J-CHiP Program administrators that identify participants and their enrollment dates. We linked these files to Medicare and Medicaid claims, and created a beneficiary-episode level analytic file for the acute care intervention and a longitudinal beneficiary level analytic file for the community intervention. Each participant-level unit of analysis (beneficiary -episode or beneficiary) contained the cost, utilization, and quality outcome measures for the study.
For the acute care intervention, comparison hospitals were chosen based on case-mix and patient demographics, and were all located in Maryland because hospitals in this state do not participate in the Inpatient Prospective Payment System (IPPS) program. Since Maryland hospitals directly submit claims to Maryland's Health Services Cost Review Commission, which are then forwarded to CMS, inconsistencies in diagnoses have been reported between preliminary and final claims and should be viewed with this in mind. For the community Intervention, the comparison pool consisted of Medicare and Medicaid data (from the VRDC and Hilltop Institute respectively) for FFS beneficiaries living in or near the same seven zip codes in East Baltimore as the J-CHiP participants.
eAppendix 2: Measure Specification
In the table below we provide definitions for the outcome measures used in the evaluation. For the acute care intervention, these measures are calculated at the beneficiary-episode level, and the table in the main report shows the weighted aggregate (weighted by the quarterly estimates) for all episodes during the intervention period. For the community intervention the outcomes are estimated at the beneficiary level, and the aggregate is calculated from the (weighted quarterly estimates) for all beneficiaries during the intervention period. We used binary measures of utilization, whether an event occurred in each quarter for a specific beneficiary-episode or beneficiary. 
eAppendix 3: Difference-in-Differences Estimation
We use difference-in-differences (DID) analyses to assess the interventions' effectiveness. This design allows us to estimate the average treatment effect for the programs while limiting the influence of secular trends (by analyzing differences between two groups over the same period). eFigure 1 below shows how the DID is calculated. The difference in the average outcome between the intervention and the comparison group after implementation of intervention minus the difference in average outcome between the intervention and the comparison group before implementation of the intervention. For more details on this model, please see Appendix C of the HCIA Complex/High-Risk Patient Targeting, Third Annual Report. 1
Measure
Definition 90-day Long-term Care Cost ** Medicaid facility and professional costs associated with institutional and home & community based long-term care within 90-days of index hospital discharge per beneficiary-episode 90-day Prescription Drug Cost ** Medicaid costs associated with prescription drugs within 90 days of index hospital discharge per beneficiary-episode (90-day) Hospitalizations Hospitalizations for any condition at any hospital. For the acute care intervention, these are inpatient admissions that occur within 90 days of an index hospitalization discharge. For the community intervention, these are inpatient admissions during the quarter. (90-day) ED Visits Emergency department visits or observation stays not resulting in hospitalization, for any condition. For the acute care intervention, these are events that occur within 90 days of an index hospitalization discharge. For the community intervention, these are events during the quarter.
30-day Readmissions
Rehospitalizations for any condition at any hospital. For the acute care intervention, these are readmissions that occur within 90 days of an index hospitalization discharge. For the community intervention, these are readmissions during the quarter. 
: Difference-in-Differences Analysis Design
We estimate the double difference by employing mixed logit models for binary outcomes (readmissions, hospitalizations, ED visits, practitioner follow-up visits, and PAH), and generalized estimating equations (GEE) with an appropriate distributional form for cost models. The mixed models are specified using general linearized models with a binomial link and clustered standard errors for the Acute Care intervention, and mixed logit models with population averaged standard errors for the community intervention.
Estimation of Aggregate Impact. The impacts reported for each measure are obtained from DID models, as described above. The aggregate impacts are calculated by summing the quarterly impacts, weighted by the number of beneficiary episodes (for the acute care intervention) or beneficiaries (for the community intervention) in the program. The aggregate impacts are presented as the difference in the total number of beneficiary episodes (acute care intervention) or beneficiaries (community intervention) with events (e.g., episodes with 90-day hospitalizations) across the program for utilization and quality of care measures, and the net difference in total cost of care across the program. Net difference is defined as the difference between the treatment and comparison group beneficiaries in the program period, after accounting for differences noted prior to the program period.
eAppendix 4: Propensity Score Methods Overall
The propensity score models for the Medicare population (Acute Care and Community Interventions) included gender, race, disability status, dual eligibility, Hierarchical Condition Category (HCC) risk score, Medicare Severity-Diagnosis Related Group (MS-DRG) weight and type, cost and ED visits in the year prior to program enrollment. For the Medicaid population (Acute Care and Community Interventions), the propensity score model included age, gender, race/ethnicity, reason for coverage, months of coverage in the final year, and Adjusted Clinical Groups® (ACG) score, and cost and ED visits in the year prior to program enrollment.
Acute Care Intervention: Propensity Score Methods Approach
The propensity score models for the Medicare population (Acute Care and Community Interventions) included gender, race, disability status, dual eligibility, Hierarchical Condition Category (HCC) risk score, Medicare Severity-Diagnosis Related Group (MS-DRG) weight and type, cost and hospitalizations, and ED visits in the year prior to program enrollment. For the Medicaid population (Acute Care and Community Interventions), the propensity score model included age, gender, race/ethnicity, reason for coverage, months of coverage in the final year, and Adjusted Clinical Groups® (ACG) score, and cost and ED visits in the year prior to program enrollment. We use propensity score (PS) models to compute weights for the treatment and comparison beneficiary-episodes to ensure that patients in the two groups are similar with respect to observed covariates. We use relative weighting to maximize the study's power to detect differences by retaining all episodes. Beneficiary-episodes at the awardee site in the pre-and post-intervention period may be systematically different, requiring our PS model to account for four distinct groups: pre-HCIA treatment group, post-HCIA treatment group, pre-HCIA comparison group, and post-HCIA comparison Group. We estimate the PS as the probability of a patient being enrolled in the awardee's program, conditional on the patient's covariates, using multinomial logistic regression. In relative weighting, awardee episodes in the post-intervention period are given a weight of one, while weights for the other three groups are defined as the relative likelihood of being seen by the awardee in the post-intervention period.
We then compute relative weights, and empirically compare the common support of propensity scores and the standardized difference in the covariates used to compute the propensity score between the J-CHiP and comparison beneficiaries before and after weighting as shown in eFigures 2-4. In the Medicaid analysis (eFigures 3 and 4), we estimated the propensity score models separately for the dually-eligible and Medicaid only populations separately. The eFigures show that after relative weighting, we observe a high level of overlap in the distribution of estimated propensity scores across J-CHiP and comparison pre-intervention and post-intervention beneficiary-episodes.
In the weighted sample, we are able to obtain balance between the four groups on demographic and clinical covariates, comorbidities, and cost and utilization in the year prior to program enrollment. 
